175
Participants
Start Date
March 31, 2002
Primary Completion Date
April 30, 2004
Study Completion Date
April 30, 2004
anti-Interferon-gamma monoclonal antibody
University Pittsburgh Medical Center, Division of Gastroenterology, Hepatology and Nutrition, Inflammatory Bowel Disease Center, Pittsburgh
University of Virginia Health System, Charlottesville
Carolina Digestion Health Associates, Charlottesville
Atlanta Gastroenterology Associates, Atlanta
Gainesville VA Medical Center, Gainesville
Waterside Clinical Research Services, Inc., West Palm Beach
University of Kentucky Medical Center, Division of Digestive Disease & Nutrition, Lexington
The Cleveland Clinic Foundation, Cleveland
Consultants for Clinical Research, Cincinnati
Gastroenterology Specialities P.C., Lincoln
Houston Medical Research Associates, Houston
Advanced Clinical Research Institute, Anaheim
Doctor's Office, Orange
Doctor's Office, Chicago
Massachusetts General Hospital, Gastrointestinal Unit, Boston
Vancouver General Hospital, Dept. of Medicine, Vancouver
Health Science Centre, Winnipeg
Queen Elizabeth II Health Science Center, McKenzie Building, Pathology, Halifax
London Health Science Center, University Campus, London
Lead Sponsor
Facet Biotech
INDUSTRY